Post-Discharge Pharmacist-led Rapid Medication Optimization for Heart Failure (Post-Discharge PHARM-HF)

Last updated: February 21, 2025
Sponsor: University of British Columbia
Overall Status: Terminated

Phase

N/A

Condition

Chest Pain

Congestive Heart Failure

Heart Failure

Treatment

Pharmacist co-management of HF medication optimization

Usual care

Pharmacist co-management of HFrEF medication optimization

Clinical Study ID

NCT06450522
H24-00300
  • Ages > 19
  • All Genders

Study Summary

This study will recruit 100 patients from a post-discharge medicine clinic to test if the addition of a pharmacist to manage heart failure medications can increase appropriate use of these medications. Participants will be randomly assigned to usual care alone or with the addition of a pharmacist to help manage medications. They will be followed for 3 months by telephone/electronically-administered questionnaires, and 12 months using administrative health records. Outcome data will include information from patients on quality of life, treatment burden, medication adherence, as well as information from their medical record on heart failure events.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age ≥19 years;

  2. Attending their initial visit to the PDMC;

  3. Diagnosis of HF.

Exclusion

Exclusion Criteria:

  • None.

Study Design

Total Participants: 12
Treatment Group(s): 3
Primary Treatment: Pharmacist co-management of HF medication optimization
Phase:
Study Start date:
July 04, 2024
Estimated Completion Date:
February 21, 2025

Connect with a study center

  • St. Paul's Hospital

    Vancouver, British Columbia V6Z 1Y6
    Canada

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.